Jinlei Bian

Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity

Jinlei Bian, Jie Ren, Yongren Li et al. · Bioorganic Chemistry · 2018 · 128 citations

Antitumor Activity, Medicine, Cancer Biology +8

NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction

Chao Zhang, Huijie Wang, Qichao Bao et al. · Oncotarget · 2016 · 117 citations · Full text

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Xi Xu, Ying Meng, Lei Li et al. · Journal of Medicinal Chemistry · 2018 · 105 citations · Full text

Gls Inhibitors, Medicinal Chemistry, Glutamine Metabolism +15

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion

Xiaqiu Qiu, Yuan‐Qing Li, Bin Yu et al. · European Journal of Medicinal Chemistry · 2020 · 79 citations · Full text

Protac Conversion, Chemoprevention Strategy, Antiproliferative Activity +8

Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer

Minzan Zuo, Xi Xu, Zhouling Xie et al. · European Journal of Medicinal Chemistry · 2016 · 55 citations

Medicinal Chemistry, Pharmaceutical Science, Indoline Thiohydantoin Derivatives +9